AI Summary
Thinking
Thinking
We reviewed 12 live results for lek investment fund and narrowed them down to the 3 options that look most worth comparing first.
The options are Growth Investment Fund, Equity Valuation: Models from Leading Investment Banks and Lek.
Source: Simplicity
Description
Simplicity Growth Investment Fund is a diversified investment fund designed for long-term growth with a minimum suggested investment timeframe of 9 years. The fund allocates 80% to growth assets (including 59% international shares, 12.4% New Zealand shares, and 8.6% unlisted property) and 20% to income assets (including cash and fixed interest). With over 4,000 investments across more than 20 countries, it offers low management fees of 0.24% per annum.
Best for
Investors seeking long-term growth and Investing with a 9+ year timeframe and tolerance for volatility
Rate this product
Source: Wiley-VCH
Description
Equity Valuation: Models from Leading Investment Banks, edited by Jan Viebig, Thorsten Poddig, and Armin Varmaz and published by John Wiley & Sons, is a 438-page finance book exploring core valuation frameworks used by top investment banks such as Morgan Stanley, UBS, Credit Suisse, Goldman Sachs, and DWS. It covers discounted cash flow models, Monte Carlo FCFF simulations, excess return and CFROI frameworks, ModelWare intrinsic value analysis, and leveraged buyout techniques for practitioners.
Best for
investment professionals, corporate managers, learning investment bank valuation methodologies and estimating cash flows and discount rates
Rate this product
Source: Unknown source
Description
Lek is a pharmaceutical company operating in the healthcare sector, known for launching biosimilar products in Slovenia.
Rate this product
| Compare | #1Growth Investment Fund | #2Equity Valuation: Models from Leading Investment Banks | #3Lek |
|---|---|---|---|
| Source | Simplicity | Wiley-VCH | Unknown source |
| Description | Simplicity Growth Investment Fund is a diversified investment fund designed for long-term growth with a minimum suggested investment timeframe of 9 years. The fund allocates 80% to growth assets (including 59% international shares, 12.4% New Zealand shares, and 8.6% unlisted property) and 20% to income assets (including cash and fixed interest). With over 4,000 investments across more than 20 countries, it offers low management fees of 0.24% per annum. | Equity Valuation: Models from Leading Investment Banks, edited by Jan Viebig, Thorsten Poddig, and Armin Varmaz and published by John Wiley & Sons, is a 438-page finance book exploring core valuation frameworks used by top investment banks such as Morgan Stanley, UBS, Credit Suisse, Goldman Sachs, and DWS. It covers discounted cash flow models, Monte Carlo FCFF simulations, excess return and CFROI frameworks, ModelWare intrinsic value analysis, and leveraged buyout techniques for practitioners. | Lek is a pharmaceutical company operating in the healthcare sector, known for launching biosimilar products in Slovenia. |
| Best for | Investors seeking long-term growth and Investing with a 9+ year timeframe and tolerance for volatility | investment professionals, corporate managers, learning investment bank valuation methodologies and estimating cash flows and discount rates | |
| Action | Simplicity | Wiley-VCH | |
| Rate this product |
"Growth Investment Fund from Simplicity."
Note: TopFind AI compiles financial product information for general comparison purposes only. It does not constitute financial advice.